Lidén Mattias, Ejerhed Lars, Sernert Ninni, Laxdal Gauti, Kartus Jüri
Department of Plastic Surgery, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden.
Am J Sports Med. 2007 May;35(5):740-8. doi: 10.1177/0363546506298275. Epub 2007 Feb 9.
The aim of the study was to compare the results after arthroscopic anterior cruciate ligament (ACL) reconstruction using central-third bone-patellar tendon-bone (BTB) autografts and triple/quadruple semitendinosus (ST) autografts.
In the long-term, ACL reconstruction using BTB autografts will render more donor-site problems than ST autografts.
Randomized controlled trial; Level of evidence, 1.
A randomized series of 71 patients (22 women and 49 men) with a unilateral ACL rupture who underwent reconstructive surgery were included in the study. The BTB graft was used in 34 patients (BTB group) and the ST-tendon graft was used in 37 patients (ST group). The patients were examined a median of 86 months (range, 68 to 114 months) after the reconstruction.
Sixty-eight of 71 patients (96%) were examined at follow-up. The clinical assessments at follow-up revealed no significant differences between the BTB group and the ST group in terms of the Lysholm score, Tegner activity level, International Knee Documentation Committee evaluation system, 1-legged hop test, KT-1000 arthrometer laxity measurements, manual Lachman test, and range of motion. A significant improvement was seen in both groups compared with the preoperative values in terms of most clinical assessments. Donor-site morbidity in the form of knee-walking ability, kneeling ability, and area of disturbed anterior knee sensitivity revealed no significant differences between the groups.
Seven years after ACL reconstruction, the subjective and objective outcomes were similar after using the central-third BTB autograft and triple/quadruple ST autograft. Furthermore, no difference in terms of donor-site morbidity was found between the 2 groups.
本研究的目的是比较使用中央三分之一髌腱-骨(BTB)自体移植物和三联/四联半腱肌(ST)自体移植物进行关节镜下前交叉韧带(ACL)重建后的结果。
从长期来看,使用BTB自体移植物进行ACL重建比使用ST自体移植物会产生更多供区问题。
随机对照试验;证据等级,1级。
本研究纳入了71例单侧ACL断裂并接受重建手术的患者(22例女性和49例男性)。34例患者使用BTB移植物(BTB组),37例患者使用ST肌腱移植物(ST组)。在重建术后中位数86个月(范围68至114个月)对患者进行检查。
71例患者中有68例(96%)在随访时接受了检查。随访时的临床评估显示,BTB组和ST组在Lysholm评分、Tegner活动水平、国际膝关节文献委员会评估系统、单腿跳测试、KT-1000关节测压计松弛度测量、手动Lachman试验和活动范围方面没有显著差异。与术前值相比,两组在大多数临床评估方面均有显著改善。两组在以膝关节行走能力、跪姿能力和前膝感觉受干扰区域形式的供区发病率方面没有显著差异。
ACL重建7年后,使用中央三分之一BTB自体移植物和三联/四联ST自体移植物后的主观和客观结果相似。此外,两组在供区发病率方面没有差异。